Open access
54
Views
5
CrossRef citations to date
0
Altmetric
Methodology
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Alexander GG Turpie1 Department of Medicine, Hamilton Health Sciences, General Division, Ontario, CanadaCorrespondence[email protected]
, André C Schmidt2 Bayer Healthcare Pharmaceuticals, Global Development, Berlin, Germany
, Reinhold Kreutz3 Institut für Klinische Pharmakologie und Toxikologie, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany
, Michael R Lassen4 Department of Orthopaedics, Spine Clinic, Clinical Trial Unit, Hørsholm Hospital, University of Copenhagen, Hørsholm, Denmark
, Waheed Jamal2 Bayer Healthcare Pharmaceuticals, Global Development, Berlin, Germany
, Lorenzo Mantovani5 Faculty of Pharmacy, Federico II University of Naples, Naples, Italy
& Sylvia Haas6 Institut für Experimentelle Onkologie und Therapieforschung, TU München, Germany
show all
Pages 363-370
|
Published online: 01 Jun 2012
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.